Remove Containment Remove Cosmetics Remove Gene
article thumbnail

Biologic Therapeutics Development, Part 2: Regulatory Pathways and Pharmacometric Analysis

Camargo

Both the FDA’s Center for Drug Evaluation and Research (CDER) and its Center for Biologics Evaluation and Research (CBER) have regulatory responsibility for therapeutic biological products, which are subject to both the Federal Food, Drug and Cosmetic (FD & C) Act and the Public Health Service (PHS) Act. Product Type-Specific Analysis.

article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog

Since that time, it was formalized in FDA regulations (21 CFR 314 Subpart H) in 1992, codified in the Food, Drug, & Cosmetic Act by FDAMA (21 USC 356(c)) in 1997, revised by FDASIA in 2012, and described in guidance, most importantly, in the 2014 Expedited Programs for Serious Conditions Drugs and Biologics (2014 Guidance).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook

Delveinsight

Erythropoietic protoporphyria is a rare inherited metabolic disorder that is a result of a deficiency or inappropriate functioning of the enzyme ferrochelatase (FECH) owing to mutations in the FECH gene. Some patients with EPP often report another mutation in the ALAS2 gene, and this condition is referred to as X?linked

article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). For additional information, please visit [link]. About Crescita Therapeutics Inc.

article thumbnail

From Gene to Protein: The Journey of Protein Expression Technology

Roots Analysis

In addition, other industries, such as agriculture, cosmetics, food, environmental sciences, biomedical research and enzyme synthesis industry, are also benefiting from the protein expression process. Protein expression process can be divided into following steps: Transcription: The DNA sequence of a gene is transcribed into mRNA.

Protein 40
article thumbnail

Liposome: A Novel Drug Delivery System

Roots Analysis

The hydrophobic portion contains two fatty acid chains with 10-24 carbon atoms, while the hydrophilic part primarily consists of phosphoric acid linked to a water-soluble molecule. Pharmaceutical and Industrial Applications of Liposomes Liposomes are frequently used for the delivery of drugs, genes, vaccines, and diagnostic products.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

It contains the antiviral medications nirmatrelvir and ritonavir. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. billion in 2022.

Sales 98